Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Anticipating budget challenges can save you from financial stress. Learn effective strategies to identify and prepare for potential hurdles.
12,161 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Pediatrix Medical Group stock tumbled on Thursday after earnings highlighted modest revenue pressures and GAAP vs non...
When a crypto exchange missteps, the ripple is felt beyond traders. This article explores why south korean lawmakers ...
Phoebe Gates leads Phia, an AI shopping startup, through a $35 million fundraising round that values the company at a...
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
Keurig Dr Pepper reported stronger-than-expected Q4 results and unveiled an $18 billion deal to acquire JDE Peet's, p...
C3.AI reports two consecutive quarterly revenue declines, forcing investors to reassess its enterprise AI strategy as...
The U.S. Treasury proposes a drastic sanction to cut a Swiss bank off from dollar clearing amid suspected Iran and Ru...
Retail traders are shifting capital from crypto to stocks, marking a sharp pivot after Bitcoin's peak. January 2026 s...
Today’s surge surprised many investors as Paramount Skydance climbed sharply while broader markets slipped. This arti...
Gates Capital Management just raised its TIC Solutions position even as TIC’s stock fell this year. Learn what this m...
Kickstarter’s stands 4-day workweek, a bold move for a remote-first company. The CEO says it balances life with high ...